Table 1. Patients’ characteristics (n(%) or median (IQR)).
| High HDL | Low HDL | p | |
| N = 250 | N = 362 | ||
| Risk factors | |||
| Age, years | 68(57–79) | 65(52–77) | 0.007 |
| Female | 60(24) | 99(27) | 0.353 |
| BMI, kg/m2 | 26(24–29) | 27(25–30) | 0.002 |
| Hypertension | 136(55) | 200(55) | 0.934 |
| Hypercholesterolemia | 111(44) | 155(43) | 0.658 |
| Family history of CAD | 65(26) | 100(28) | 0.521 |
| Diabetes | 45(18) | 86(24) | 0.085 |
| Smoking | 62(25) | 130(36) | 0.002 |
| Prior myocardial infarction | 27(11) | 65(18) | 0.015 |
| Clinical data | |||
| HR, beats/min | 77(67–90) | 76(66–88) | 0.542 |
| SBP, mmHg | 140(121–163) | 137(120–160) | 0.308 |
| DBP, mmHg | 80(70–96) | 80(69–90) | 0.093 |
| STEMI | 147(59) | 188(52) | 0.093 |
| LVEF, % | 55(45–60) | 55(45–60) | 0.670 |
| Current medications | |||
| Statin | 66(26) | 92(25) | 0.784 |
| Fibrate | 7(3) | 23(6) | 0.045 |
| ACE inhibitor | 42(17) | 74(20) | 0.258 |
| Aspirin | 56(22) | 78(21) | 0.802 |
Low HDL was defined as <40 mg/dL in men and <50 mg/dL in women.
ACE: Angiotensin converting enzyme; BMI: body mass index; CAD: Coronary artery disease; DBP: Diastolic blood pressure; HR: heart rate; LVEF: Left ventricular ejection fraction; SBP: Systolic blood pressure; STEMI: ST segment elevation myocardial infarction.